MG
PRCT icon

Michael Gelband’s Procept Biorobotics PRCT Stock Holding History

Michael Gelband’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Buy
+96,376
New +$2.41M 0.01% 784
2026
Q1 		– Sell
-237,198
Closed -$7.46M – 1986
2025
Q4 		$7.46M Buy
+237,198
New +$7.87M 0.06% 338
2025
Q3 		– Sell
-48,021
Closed -$2.77M – 1918
2025
Q2 		$2.77M Buy
+48,021
New +$2.72M 0.02% 626
2023
Q2 		– Sell
-338,950
Closed -$9.63M – 2174
2023
Q1 		$9.63M Buy
+338,950
New +$12M 0.08% 287
2022
Q2 		– Sell
-16,863
Closed -$590K – 2340
2022
Q1 		$590K Buy
+16,863
New +$406K 0.01% 1439

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Michael Gelband's PRCT Position: Q2 2026 in Review

Michael Gelband opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 96,376 shares worth $2.18M. The stake represents 0.01% of the portfolio and ranks #784 among its holdings. This is a return to the name: Michael Gelband previously reported a position in PRCT as recently as Q4 2025.

Michael Gelband first reported a position in PRCT in Q1 2022 and has held it in 5 quarters since. The position peaked at $9.63M in Q1 2023. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Michael Gelband held 96,376 shares of Procept Biorobotics worth $2.18M as of Q2 2026.
  • Procept Biorobotics was a new Michael Gelband position in Q2 2026.
  • Procept Biorobotics made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #784 holding.
  • Michael Gelband first reported a position in Procept Biorobotics in Q1 2022 and has held it in 5 quarters since.
  • Michael Gelband's Procept Biorobotics position peaked at $9.63M in Q1 2023.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.